ReP USP - Resultado da busca

Artigo de periodico
Geographic distribution of the 3435C>T polymorphism of the MDR1 gene in Peruvian populations (2019)
Valencia Ayala, Edward ; Marcos Carbajal, Pool; Coelho, Eduardo Barbosa ; Sandoval, Jose Sandoval; Salazar-Granara, Alberto
Source: Drug Metabolism and Personalized Therapy. Unidade: FMRP
Subjects: GRUPOS ÉTNICOS, POLIMORFISMO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALENCIA AYALA, Edward et al. Geographic distribution of the 3435C>T polymorphism of the MDR1 gene in Peruvian populations. Drug Metabolism and Personalized Therapy, v. 34, n. 3, p. [7] , 2019Tradução . . Disponível em: https://doi.org/10.1515/dmpt-2018-0041. Acesso em: 06 out. 2024.
APA
Valencia Ayala, E., Marcos Carbajal, P., Coelho, E. B., Sandoval, J. S., & Salazar-Granara, A. (2019). Geographic distribution of the 3435C>T polymorphism of the MDR1 gene in Peruvian populations. Drug Metabolism and Personalized Therapy, 34( 3), [7] . doi:10.1515/dmpt-2018-0041
NLM
Valencia Ayala E, Marcos Carbajal P, Coelho EB, Sandoval JS, Salazar-Granara A. Geographic distribution of the 3435C>T polymorphism of the MDR1 gene in Peruvian populations [Internet]. Drug Metabolism and Personalized Therapy. 2019 ; 34( 3): [7] .[citado 2024 out. 06 ] Available from: https://doi.org/10.1515/dmpt-2018-0041
Vancouver
Valencia Ayala E, Marcos Carbajal P, Coelho EB, Sandoval JS, Salazar-Granara A. Geographic distribution of the 3435C>T polymorphism of the MDR1 gene in Peruvian populations [Internet]. Drug Metabolism and Personalized Therapy. 2019 ; 34( 3): [7] .[citado 2024 out. 06 ] Available from: https://doi.org/10.1515/dmpt-2018-0041
Artigo de periodico
The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries (2017)
Costa, A. C. C.; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia; Correia, B. V.; Abumansur, Juliana Trench; Lauretti, Gabriela Rocha; Moraes, N. V. de
Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOGENÉTICA, FARMACOCINÉTICA, POLIMORFISMO, BLOQUEIO NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, A. C. C. et al. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, v. 73, n. 8, p. 957-963, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00228-017-2243-1. Acesso em: 06 out. 2024.
APA
Costa, A. C. C., Coelho, E. B., Lanchote, V. L., Correia, B. V., Abumansur, J. T., Lauretti, G. R., & Moraes, N. V. de. (2017). The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, 73( 8), 957-963. doi:10.1007/s00228-017-2243-1
NLM
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Vancouver
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Artigo de periodico
Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers (2016)
Antunes, Natalícia de Jesus; Wichert-Ana, Lauro; Coelho, Eduardo Barbosa; Pasqua, Oscar Della; Alexandre Junior, Veriano; Takayanagui, Osvaldo Massaiti; Tozatto, Eduardo; Marques, Maria Paula; Lanchote, Vera Lúcia
Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: ANTICONVULSIVANTES, FARMACOCINÉTICA CLÍNICA, MOLÉCULA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus et al. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European Journal of Clinical Pharmacology, v. 72, n. 2, p. 195-201, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00228-015-1970-4. Acesso em: 06 out. 2024.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Pasqua, O. D., Alexandre Junior, V., Takayanagui, O. M., et al. (2016). Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European Journal of Clinical Pharmacology, 72( 2), 195-201. doi:10.1007/s00228-015-1970-4
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 2): 195-201.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00228-015-1970-4
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 2): 195-201.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00228-015-1970-4
Artigo de periodico
Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer (2011)
Fernandes, Bruno José Dumêt; Silva, Carolina de Miranda; Andrade, Jurandyr Moreira; Matthes, Ângelo do Carmo Silva; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Cancer Chemotherapy and Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, FARMACOCINÉTICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Bruno José Dumêt et al. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer. Cancer Chemotherapy and Pharmacology, v. 68, n. 4, p. 897-904, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00280-011-1554-7. Acesso em: 06 out. 2024.
APA
Fernandes, B. J. D., Silva, C. de M., Andrade, J. M., Matthes, Â. do C. S., Coelho, E. B., & Lanchote, V. L. (2011). Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer. Cancer Chemotherapy and Pharmacology, 68( 4), 897-904. doi:10.1007/s00280-011-1554-7
NLM
Fernandes BJD, Silva C de M, Andrade JM, Matthes Â do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00280-011-1554-7
Vancouver
Fernandes BJD, Silva C de M, Andrade JM, Matthes Â do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00280-011-1554-7
Artigo de periodico
Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer (2011)
Fernandes, Bruno José Dumêt; Silva, Carolina de Miranda; Andrade, Jurandyr Moreira de; Matthes, Ângelo do Carmo Silva; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Cancer Chemotherapy and Pharmacology. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, FARMACOTERAPIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Bruno José Dumêt et al. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer. Cancer Chemotherapy and Pharmacology, v. 68, n. 4, p. 897-904, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00280-011-1554-7. Acesso em: 06 out. 2024.
APA
Fernandes, B. J. D., Silva, C. de M., Andrade, J. M. de, Matthes, Â. do C. S., Coelho, E. B., & Lanchote, V. L. (2011). Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer. Cancer Chemotherapy and Pharmacology, 68( 4), 897-904. doi:10.1007/s00280-011-1554-7
NLM
Fernandes BJD, Silva C de M, Andrade JM de, Matthes Â do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00280-011-1554-7
Vancouver
Fernandes BJD, Silva C de M, Andrade JM de, Matthes Â do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00280-011-1554-7
Artigo de periodico
Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers (2008)
Rocha, Adriana; Coelho, Eduardo Barbosa; Moussa, Soraia A. P.; Lanchote, Vera Lúcia
Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: GASTROENTEROLOGIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Adriana et al. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers. European Journal of Clinical Pharmacology, v. 64, n. 9, p. 901-906, 2008Tradução . . Disponível em: https://doi.org/10.1007/s00228-008-0510-x. Acesso em: 06 out. 2024.
APA
Rocha, A., Coelho, E. B., Moussa, S. A. P., & Lanchote, V. L. (2008). Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers. European Journal of Clinical Pharmacology, 64( 9), 901-906. doi:10.1007/s00228-008-0510-x
NLM
Rocha A, Coelho EB, Moussa SAP, Lanchote VL. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 901-906.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00228-008-0510-x
Vancouver
Rocha A, Coelho EB, Moussa SAP, Lanchote VL. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 901-906.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00228-008-0510-x
Artigo de periodico
Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus (2002)
Marques, Maria Paula; Coelho, Eduardo Barbosa; Santos, Neife Aparecida Guinaim; Geleilete, Tufik José Magalhães; Lanchote, Vera Lúcia
Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Assunto: FARMACOLOGIA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARQUES, Maria Paula et al. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. European Journal of Clinical Pharmacology, v. 58, n. 9, p. 607-614, 2002Tradução . . Disponível em: https://doi.org/10.1007/s00228-002-0528-4. Acesso em: 06 out. 2024.
APA
Marques, M. P., Coelho, E. B., Santos, N. A. G., Geleilete, T. J. M., & Lanchote, V. L. (2002). Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. European Journal of Clinical Pharmacology, 58( 9), 607-614. doi:10.1007/s00228-002-0528-4
NLM
Marques MP, Coelho EB, Santos NAG, Geleilete TJM, Lanchote VL. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus [Internet]. European Journal of Clinical Pharmacology. 2002 ; 58( 9): 607-614.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00228-002-0528-4
Vancouver
Marques MP, Coelho EB, Santos NAG, Geleilete TJM, Lanchote VL. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus [Internet]. European Journal of Clinical Pharmacology. 2002 ; 58( 9): 607-614.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s00228-002-0528-4

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Indexado em

Non normalized affiliation